Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation

Koudriavtseva, TatianaMainero, Caterina2016-06-142016Koudriavtseva, Tatiana, and Caterina Mainero. 2016. “Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation.” Frontiers in Human Neuroscience 10 (1): 226. doi:10.3389/fnhum.2016.00226. http://dx.doi.org/10.3389/fnhum.2016.00226.1662-5161http://nrs.harvard.edu/urn-3:HUL.InstRepos:27320314en-USOpinionmultiple sclerosisbrain atrophyinflammationneuroprotectiondisease modifying therapyBrain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of InflammationJournal Article2016-06-1410.3389/fnhum.2016.00226